Immune-related response assessment during PD-1 inhibitor therapy in advanced non-small-cell lung cancer patients

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2016

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 14 tweets from 9 users, with an upper bound of 28,711 followers.

RT @sitcancer: New #JITC: Immune-related response assessment during PD-1 inhibitor therapy in advanced #NSCLC patients https://t.co/V7wXvAX…

RT @sitcancer: New #JITC: Immune-related response assessment during PD-1 inhibitor therapy in advanced #NSCLC patients https://t.co/V7wXvAX…

New #JITC: Immune-related response assessment during PD-1 inhibitor therapy in advanced #NSCLC patients https://t.co/V7wXvAXjbX #LungCancer

RT @PDRennert: Varied response of metastatic lesions across organs in #nivolumab treated NSCLC pts https://t.co/f1jbuidec3 go mouse model…

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 10 additional tweets.